SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000792977-19-000140
Filing Date
2019-12-03
Accepted
2019-12-03 16:13:05
Documents
15
Period of Report
2019-11-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K amag8-k12319.htm   iXBRL 8-K 36808
7 amag_rgb.jpg GRAPHIC 151973
  Complete submission text file 0000792977-19-000140.txt   522494

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amag-20191129.xsd EX-101.SCH 4588
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amag-20191129_cal.xml EX-101.CAL 624
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amag-20191129_def.xml EX-101.DEF 1474
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amag-20191129_lab.xml EX-101.LAB 26142
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amag-20191129_pre.xml EX-101.PRE 13580
12 EXTRACTED XBRL INSTANCE DOCUMENT amag8-k12319_htm.xml XML 4221
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 191265933
SIC: 2834 Pharmaceutical Preparations